(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

KROPSEN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

KROPSEN

ST13

US500000090806791

Class

5

Filing

90806791

Registration

6767764

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

22

Latest update

06/21/2022

Classification

Registered

Trademark type

Combined

Nice classes

5

Filing date

07/01/2021

Registration date

06/21/2022

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/21/2022

Last transaction

06/21/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

3

Owner type

99

Owner location

Suzhou City, CN

Examiner

SALES, HEATHER

Law office

O30

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized wording "KROPSEN" wherein an arc design beginning from the bottom letter "K", extending through the letter "K" and to the top of the letter "R", with an arrow design above the right side of the arc.

Holders and representatives

Holders

Suzhou Kintor Pharmaceuticals, Inc.

Representatives

Bharati Bakshani LADAS & PARRY, LLP

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Chemical preparations for pharmaceutical or medical purposesfor prevention and treatment of cancer; Tumor suppressing agents; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations for the preventiondiagnosistreatment and adjunctive therapy of coronavirusesCovid-19influenza virusesinfluenza Ainfluenza BSARS-CoV-1SARSCoV-2MERS-CoVrhinoviruses; Mixed biological preparations for the prevention and treatment of infectious diseases; Biological preparations for the treatment of cancer; Anti-cancer pharmaceutical preparations; Medicinal preparations for stimulating hair growth; Medicines for the treatment of cardiovascular and cerebrovascular diseases; Pharmaceutical products for the prevention and treatment of cancer; Medicinal hair growth preparations; Acne treatment pharmaceutical preparations; Pharmaceutical products for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; Nutraceuticals for the treatment of infectious diseasesinflammationalopeciacancer

Publications

History of USPTO decisions and trademark events.

22 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/21/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

06/21/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/05/2022

PUBO

PUBLISHED FOR OPPOSITION

04/05/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/16/2022

PREV

LAW OFFICE PUBLICATION REVIEW COMPLETED

03/01/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/01/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

02/24/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

02/24/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

02/24/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

02/24/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/16/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/16/2022

ALIE

ASSIGNED TO LIE

02/16/2022

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/14/2022

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/12/2022

GNSL

LETTER OF SUSPENSION E-MAILED

01/12/2022

CNSL

SUSPENSION LETTER WRITTEN

01/12/2022

DOCK

ASSIGNED TO EXAMINER

01/10/2022

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/14/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/13/2021

NWAP

NEW APPLICATION ENTERED

07/05/2021

Continuous trademark protection

Get notified about every new filing that threatens KROPSEN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.